← back to search

Fiona E. McRonald

National Cancer Registration Service ·
Area of research
Pulmonary and Respiratory Medicine · Genetics
Research interest
Research interests include Lung Cancer Diagnosis and Treatment, BRCA gene mutations in cancer, Genetic factors in colorectal cancer, and Lung Cancer Treatments and Mutations.
h-index
22
citations
3,487
works
66
NIH funding
primary concept
Medicine
email

Recent publications

Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort study
The Lancet Regional Health - Europe 2024cited by 22position: middledoi
Second Primary Cancer Risks After Breast Cancer in <i>BRCA1</i> and <i>BRCA2</i> Pathogenic Variant Carriers
Journal of Clinical Oncology 2024cited by 20position: middledoi
Lung adenocarcinoma promotion by air pollutants
Nature 2023cited by 728position: middledoi
Recommendations for laboratory workflow that better support centralised amalgamation of genomic variant data: findings from CanVIG-UK national molecular laboratory survey
Journal of Medical Genetics 2023cited by 4position: middledoi
Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up
Cancer Prevention Research 2022cited by 52position: middledoi
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
The Lancet Regional Health - Europe 2021cited by 221position: middledoi
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial
The Lancet 2020cited by 400position: middledoi
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
Health Technology Assessment 2016cited by 287position: middledoi
UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
Thorax 2015cited by 338position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Nicholas Wald · University College London2 papers (2015–2016)Kate Brain · Cardiff University2 papers (2015–2016)Ghasem Yadegarfar · Isfahan University of Medical Sciences2 papers (2015–2016)Kate Lifford · University of Edinburgh2 papers (2015–2016)David Baldwin · University of Nottingham2 papers (2015–2016) · 2 papers (2015–2016)Robert C. Rintoul · University of Cambridge2 papers (2015–2016)Arjun Nair · Neurological Surgery2 papers (2015–2016)Richard D. Page · Center for Cancer and Blood Disorders2 papers (2015–2016)David M. Hansell · Australian National University2 papers (2015–2016)Anand Devaraj · University of Edinburgh2 papers (2015–2016)M.J. Ledson · University of Liverpool2 papers (2015–2016)John A. Holemans · University of Liverpool2 papers (2015–2016)Mahesh Parmar · MRC Clinical Trials Unit at UCL2 papers (2015–2016)David Weller · University of Edinburgh2 papers (2015–2016)John K. Field · University of Liverpool2 papers (2015–2016)Stephen W. Duffy · University of Pittsburgh Medical Center2 papers (2015–2016)Bethany Torr · Royal Marsden NHS Foundation Trust1 papers (2024–2024)Faye Elliott · University of Leeds1 papers (2022–2022)Harsh Sheth · North West London Pathology1 papers (2022–2022)